US EditionJazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth - Pharmafile
Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president and chief operating officer (COO), succeeds co-founder Bruce Cozadd, who will retire as CEO and continue as chairperson of the board. The appointment follows a thorough succession process led by the board. Galá brings more […] The post Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium